eng Oriental Scientific Publishing Company Biomedical and Pharmacology Journal 0974-6242 2020-06-25 13 2 711 715 10.13005/bpj/1936 34178 article Nicolas Padilla-Raygoza 1 Cuauhtémoc Sandoval- Salazar 2 Vicente Beltrán-Campos 3 Xóchitl Sofía Ramírez-Gómez 3 María de Jesús Gallardo-Luna 4 Efrain Navarro-Olivos 4 School of Medicine, University of Celaya, Celaya, México, CP 38080 Department of Nursing and Obstetrics, Division of Health Sciences and Engineering, Campus Celaya-Salvatierra, University of Guanajuato, Celaya, México, CP 38060 Clinical Nursing, Division of Health Sciences and Engineering, Campus Celaya-Salvatierra, University of Guanajuato, Celaya, México, CP 38140 Institute of Public Health from Guanajuato State, Guanajuato, México CP36,000 Orcid ID:0000-0001-5807-8140 The aim was to describe the clinical data from patients with confirmed cases of COVID-19 and clinical data of patients with pneumonia by the same virus. It was selected articles on clinical data from patients with COVID-19 and pneumonia by SARS-CoV-2 in pubmed, embase and google schoolar. It was described the clinical data of patients with COVID-19 from 3 studies with 1,078 patients. The main clinical data for COVID-19 were cough 60.4%, fever 40.9%, and production of sputum 26.0%. For pneumonia by SARS-CoV-2, was described clinical data from 495 patients from 5 studies, were fever 77.4%, cough 68.9%, and myoarthralgia 49.9%. In children with COVID-19 was reported cough 48.5%, pharyngeal erythema 46,2%, and fever 41.5%. To use only clinical data to submit patients to RT-PCR test is not good, because many infected patients have not clinical data (asymptomatic carriers) or they did not reported the main clinical data as fever, cough or myoarthralgia. https://biomedpharmajournal.org/vol13no2/sars-cov-2-infection-and-coronavirus-disease-covid-19-clinical-data-a-review-of-the-literature/ COVID-19 Pneumonia Signs Symptoms SARS-CoV-2